Research Questions in Obstructive Pulmonary †MyAssignmenthelp.com

Question: Discuss about the Research Questions in Obstructive Pulmonary. Answer: Introduction: According to (Guirguis et al 2016), the Chronic obstructive pulmonary disease is mainly attributed to the limitation of the air flowing within the respiratory organs and its partially irreversible. The primary cause of the disease in the developed states is tobacco smoking and inhalation of outdoor and indoor contaminated airways. The other source is inhalation of occupational contaminated dust, respiratory infections and chronic bronchitis. The spirometry test is done to determine the FEV1/FVC. FEV1/FVC I do have a feeling that the chronic obstructive disease could be controlled in the best way if identified earlier. Chronic obstructive pulmonary disease in its late phase shows enfeeble effects on the morbidity and mortality. Many of the patients at this stage need oxygen treatment of the disease, regular hospitalization and support. The disease is the leading to high mortality rate globally. About 80-90 % of people who die of chronic obstructive disease are characterized by smoking. Approximately, 50% of old people who smoke develop the infection. The rest who don't smoke acquire the infection from the occupational contaminated dust or exposure to noxious genetic malfunction from the contaminated air inhalation like alpha-1 (Martinez,2016). The observation has made so far, the high rate of Chronic obstructive pulmonary disease prescription budget might increase. Kruis et al ( 2015) states that most people affected with the chronic obstructive pulmonary disease are the old people. These patients most of the time will have short breath complaints, decreased confidence in their movement ability and increased anxiety. Thus, nurses need a vast knowledge in order to know how they can best treat the patients. Nurses should talk with the patients about their deteriorating ability to move and provide the best help that can improve their movement. At the final phase, the patient may turn down some advice like talking to the counsellor. Therefore, a decision should be made for anti-depressants therapy. Nurses are obliged in offering a recommendation that analyses and help in the disease management. The analysis should incorporate daily routines of the patient. The routines include, dressing, bathing, transferring and feeding. For instance, patients with disability, modification of their environment to decrease dyspnea. For example, the environmental mo dification can be achieved by introduction of chair glides on the stairs to ease their movements. Then nurses must avoid isolating the infected person with the society. The issue can be addressed by identifying social interaction resources. Best practices for chronic obstructive disease (COPD). Best practice Citation in CDU APA 6th Format Discuss with the patient on the anxiety of COPD at the final phase. (Celli et al 2015) Inputting therapy in the care of the patient like anti-depressants (Martinez et al 2015) Encourage the independence of the patient especially when he or she regains the strength. (McCarthy et al 2015) Encourage the continuous medication of the patient despite the side effects. (Pascoe et al 2015) Ensuring the patient is taking in the balanced diet (Soriano,2017). Monitor the output and input across 24hours in order to have the knowledge of any upcoming condition. (Miravitlles et al 2015) References Kruis, A. L., Boland, M. R., Assendelft, W. J., Gussekloo, J., Tsiachristas, A., Stijnen, T., ... Chavannes, N. H. (2014). Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial. bmj, 349, g5392. Celli, B. R., Decramer, M., Wedzicha, J. A., Wilson, K. C., Agust, A., Criner, G. J., ... Vogelmeier, C. (2015). An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine, 191(7), e4-e27. Lange, P., Celli, B., Agust, A., Boje Jensen, G., Divo, M., Faner, R., ... Meek, P. (2015). Lung-function trajectories leading to chronic obstructive pulmonary disease. New England Journal of Medicine, 373(2), 111-122. Martinez, F. J., Calverley, P. M., Goehring, U. M., Brose, M., Fabbri, L. M., Rabe, K. F. (2015). Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. The Lancet, 385(9971), 857-866. McCarthy, B., Casey, D., Devane, D., Murphy, K., Murphy, E., Lacasse, Y. (2015). Pulmonary rehabilitation for chronic obstructive pulmonary disease. The Cochrane Library. Miravitlles, M., Price, D., Rabe, K. F., Schmidt, H., Metzdorf, N., Celli, B. (2015). Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease. International journal of chronic obstructive pulmonary disease, 10, 549. Pascoe, S., Locantore, N., Dransfield, M. T., Barnes, N. C., Pavord, I. D. (2015). Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials. The lancet Respiratory medicine, 3(6), 435-442. Guirguis-Blake, J. M., Senger, C. A., Webber, E. M., Mularski, R. A., Whitlock, E. P. (2016). Screening for chronic obstructive pulmonary disease: evidence report and systematic review for the US preventive services task force. Jama, 315(13), 1378-1393. Martinez, F. D. (2016). Early-life origins of chronic obstructive pulmonary disease. New England Journal of Medicine, 375(9), 871-878. Soriano, J. B. (2017). An Epidemiological Overview of Chronic Obstructive Pulmonary Disease: What Can Real-Life Data Tell Us about Disease Management?. COPD: Journal of Chronic Obstructive Pulmonary Disease, 14(sup1), S3-S7.